3654 results for «278»
3654 results
GulfPCR-GIM 2021 Opening Ceremony
15 Dec 2021 – From GulfPCR-GIM 2021
Listen to the enthusiastic speeches of the 4 Course Directors who are happy to open this 10th edition of the GulfPCR-GIM Congress and to present the main highlights of a program that promises to be dense and rich.
Ultra low contrast PCI in chronic kidney disease: what tools do we have? How to perform? How to achieve optimal outcome? How low can you go?
22 Dec 2021 – From GulfPCR-GIM 2021
Don't miss this session to understand how to perform ultra-low contrast PCI in complex disease and to discover SyncVision co-registration, Dynamic Coronary Roadmap, and the benefits for Azurion to perform ultra-low contrast PCI.
Mastering PCI in patients with complex lesions, ACS and HBR
22 Dec 2021 – From GulfPCR-GIM 2021
Watch this video if you wish to learn how to treat patients with complex anatomy, HBR feature, and presenting with ACS, to discuss the latest evidence about DAPT in HBR patients with acute coronary syndrome, and to ask open questions about DAPT for HBR patients.
Align to a line: improve clinical outcome of current and future patients with the Evolut platform
22 Dec 2021 – From GulfPCR-GIM 2021
Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
Optimising TAVI results in patients with small aortic annuli
22 Dec 2021 – From GulfPCR-GIM 2021
This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.
Complete revascularisation: from defining PCI strategy to PCI optimisation
22 Dec 2021 – From GulfPCR-GIM 2021
In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.
Closing Ceremony
23 Nov 2021 – From PCR London Valves 2021
Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
27 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Ivus or angiography guidance for PCI in complex coronary bifurcation lesions (DKCRUSH-VIII)
31 Mar 2026
Nicola Ryan provides her take on DKCRUSH-VIII, a randomised controlled trial comparing IVUS versus angiography guidance for PCI, predominantly using the DKCRUSH technique in patients with complex bifurcation lesions, as presented by Shaoliang Chen at ACC.26 in New Orleans.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
